Unfortunately, my initial hands-on testing with corrupted datasets reveals a fundamental enterprise problem: impressive capabilities paired with insufficient transparency about data transformations.

Neurogen Biomarking to present novel data on at-home p-tau 217 testing for Alzheimer’s disease at Alzheimer’s Association International Conference® 2025 ...